Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (41-50 of 411) with videos related to

Pageof 42
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and TrialsJuan I Castrillo, Simone Lista, Harald Hampel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's diseaseAnnibale Antonioni, Alessandro Martorana, Emiliano Santarnecchi, et al.
Journal of Neurology|May 9, 2014
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developmentsSimone Lista, Henrik Zetterberg, Bruno Dubois, et al.
Progress in Neurobiology|July 5, 2011
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's diseaseDavid Prvulovic, Arun L W Bokde, Frank Faltraco, et al.
Progress in Neurobiology|May 24, 2011
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expressionStefan J Teipel, Ralph Buchert, Johannes Thome, et al.
Progress in Neurobiology|July 23, 2011
Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's diseaseHarald Hampel, David Prvulovic, Stefan J Teipel, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 17, 2017
Evolving Relevance of Neuroproteomics in Alzheimer's DiseaseSimone Lista, Henrik Zetterberg, Sid E O'Bryant, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
A new sandwich immunoassay for detection of the α-secretase cleaved, soluble amyloid-β protein precursor in cerebrospinal fluid and serumMara Taverna, Tobias Straub, Harald Hampel, et al.
Journal of Personalized Medicine|September 24, 2020
Biomarkers for Alzheimer's Disease (AD) and the Application of Precision MedicineWalter J Lukiw, Andrea Vergallo, Simone Lista, et al.
Frontiers in Pharmacology|April 16, 2019
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer's Precision Medicine and PharmacologyHarald Hampel, Edward J Goetzl, Dimitrios Kapogiannis, et al.
Pageof 42

Showing results (41-50 of 411) with videos related to

Sort By:
Pageof 42
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and TrialsJuan I Castrillo, Simone Lista, Harald Hampel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's diseaseAnnibale Antonioni, Alessandro Martorana, Emiliano Santarnecchi, et al.
Journal of Neurology|May 9, 2014
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developmentsSimone Lista, Henrik Zetterberg, Bruno Dubois, et al.
Progress in Neurobiology|July 5, 2011
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's diseaseDavid Prvulovic, Arun L W Bokde, Frank Faltraco, et al.
Progress in Neurobiology|May 24, 2011
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expressionStefan J Teipel, Ralph Buchert, Johannes Thome, et al.
Progress in Neurobiology|July 23, 2011
Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's diseaseHarald Hampel, David Prvulovic, Stefan J Teipel, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 17, 2017
Evolving Relevance of Neuroproteomics in Alzheimer's DiseaseSimone Lista, Henrik Zetterberg, Sid E O'Bryant, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
A new sandwich immunoassay for detection of the α-secretase cleaved, soluble amyloid-β protein precursor in cerebrospinal fluid and serumMara Taverna, Tobias Straub, Harald Hampel, et al.
Journal of Personalized Medicine|September 24, 2020
Biomarkers for Alzheimer's Disease (AD) and the Application of Precision MedicineWalter J Lukiw, Andrea Vergallo, Simone Lista, et al.
Frontiers in Pharmacology|April 16, 2019
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer's Precision Medicine and PharmacologyHarald Hampel, Edward J Goetzl, Dimitrios Kapogiannis, et al.
Pageof 42